Home › Funds › Boston Trust Walden Corp › CHE

Boston Trust Walden Corp position in CHE

CHEMED CORP NEW · Health Care

Boston Trust Walden Corp reported holding 191,501 shares of CHE (CHEMED CORP NEW) in its Q3 2026 13F filing — a position valued at US$96.7M, representing 0.78% of its reported portfolio and ranking #26 among its reported holdings. Boston Trust Walden Corp has disclosed CHE holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)191.50K sh
Reported value held$96.72M
Portfolio Weight0.78%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Boston Trust Walden Corp's CHE position evolved

Boston Trust Walden Corp first disclosed a stake in CHE in Q3 2023 at 216,337 shares (US$112.4M). The position peaked in Q1 2025 at 246,351 shares, worth US$151.6M. Across 13 filings, Boston Trust Walden Corp increased the stake 4 time(s), trimmed it 7 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 191,501 shares valued at US$96.7M — a reduction of -9,774 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 216.34K $112.43M New
Q4 2023 199.15K $116.45M Reduce
Q1 2024 210.40K $135.06M Add
Q2 2024 221.44K $120.15M Add
Q3 2024 220.07K $132.25M Reduce
Q4 2024 242.17K $128.30M Add
Q1 2025 246.35K $151.58M Add
Q2 2025 247.43K $120.48M Hold
Q3 2025 234.47K $104.98M Reduce
Q4 2025 221.24K $94.66M Reduce
Q1 2026 205.20K $77.51M Reduce
Q2 2026 201.28K $93.74M Reduce
Q3 2026 191.50K $96.72M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CHE and 13F data

CHE (CHEMED CORP NEW) is a Health Care company. 22 other funds we track also report a position in CHE — the largest reported positions include Epoch Investment Partners, Inc. (US$124.8M), River Road Asset Management, LLC (US$100.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CHE

All CHE fund holders →

FAQ

How long has Boston Trust Walden Corp held CHE?

Boston Trust Walden Corp has disclosed CHE holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Boston Trust Walden Corp's current position in CHE?

As of Q3 2026, Boston Trust Walden Corp holds 191.50K shares of CHE (CHEMED CORP NEW), valued at $96.72M, representing 0.78% of its reported portfolio and ranking #26.

Has Boston Trust Walden Corp been buying or selling CHE?

In the latest 13F filing (Q3 2026), Boston Trust Walden Corp reduced its position in CHE. The position peaked in Q1 2025 at 246.35K shares.

Which other funds hold CHE?

Other major institutional holders of CHE include Epoch Investment Partners, Inc., River Road Asset Management, LLC, among 22 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.